Lv21
160 积分 2025-07-11 加入
国家基层糖尿病防治管理指南（2025 版）
1个月前
已完结
Efficacy and safety of tirzepatide added to basal insulin in patients with type 2 diabetes in China (SURPASS-CN-INS): a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
肠促胰素类减重药物临床应用专家共识（2025版）
1个月前
已完结
“Treat to success”，指引2型糖尿病管理新方向
1个月前
已完结
国家基层肥胖症综合管理技术指南（2025）
2个月前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
2个月前
已完结
Lower Extremity Peripheral Artery Disease Without Chronic Limb-Threatening Ischemia: A Review
3个月前
已完结
Peripheral artery disease: epidemiology and global perspectives
3个月前
已完结
Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
3个月前
已完结
皖公网安备34019202002308
